22 reports

Development Of RMC-## Drug For Respiratory Diseases Treatment - The development of the RMC-## drug has enabled the blocking of the series of chain reactions that result in respiratory diseases such as asthma and COPD.

  • Cardiovascular Drug
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.

Spiriva is used to treat chronic obstructive pulmonary disease (COPD) and asthma.

  • Cardiovascular Drug
  • United States
  • World
  • Bayer AG
  • Daiichi Sankyo Company
  • Market segmentation by age group
  • Global epinephrine autoinjector market by age group 2016

You can easily book an appointment with one online.

  • Cardiovascular Drug
  • World
  • Impax Laboratories, Inc.
  • Lincoln Medical, Ltd.
  • Mylan Inc.

In the US, people suffer ## billion colds per year.

  • Cardiovascular Drug
  • Pharmaceutical
  • Prescription Drug
  • China
  • Demand

The company mainly sells drugs treating HBV, asthmas and infections.

  • Cardiovascular Drug
  • China
  • Demand
  • Supply
  • Zhejiang Expressway Co., Ltd.
  • ANTI-HYPERTENSIVE THERAPEUTICS, COMPELLING AND POSSIBLE CONTRA-INDICATIONS OF
  • 3.5 Beta Blockers

Chapter ##.

  • Cardiovascular Drug
  • World
  • Market Size
  • Daiichi Sankyo Company
  • Novartis AG

OTHER MEDICAL CONDITIONS ALSO ASSOCIATED WITH AF INCLUDE DIABETES, HYPERTHYROIDISM, PNEUMONIA, PULMONARY EMBOLISM (PE), LUNG CARCINOMA, AND CHRONIC LUNG DISEASES SUCH AS ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD).

  • Cardiovascular Drug
  • Market Size
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company

The auto exports exceeded over ## million each year.

  • Cardiovascular Drug
  • China
  • Demand
  • Forecast
  • Market Size

THE AUTO EXPORTS EXCEEDED OVER ## MILLION EACH YEAR.

  • Cardiovascular Drug
  • China
  • Demand
  • AstraZeneca China Inc.
  • Sanofi-Synthelabo Inc.
  • Anticoagulants pipeline portfolio

You can easily book an appointment with one online.

  • Cardiovascular Drug
  • United States
  • Boehringer Ingelheim GmbH
  • Johnson & Johnson
  • Sanofi S.A.

Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) INTRODUCTION Chapter I THE CURRENT MARKET FOR HYPERTENSION DRUGS IN CHINA IS GROWING RAPIDLY.

  • Cardiovascular Drug
  • China
  • AstraZeneca China Inc.
  • Hangzhou MSD Pharmaceutical Co., Ltd
  • Sanofi-Synthelabo Inc.

About ## in ## people (about ## Million) with asthma had an asthma attack in 2008, but many asthma attacks could have been prevented.

  • Cardiovascular Drug
  • Pharmaceutical
  • United States
  • Forecast
  • Pfizer Inc.

Drivers and their Impact Impact on End-user Category Driver Expiry of Patents Increased Investment in Healthcare Infrastructure Hospitals Low Low ## ## ## ## ## High Low Pharmaceutical Stores High ## ## ## ## ## High Low High ## ## ## ## ## ## ## ## ## ## Cost Factor Increase in Elde

  • Anti-Infective
  • Cardiovascular Drug
  • Japan
  • Meiji Seika Pharma Co., Ltd.
  • Nipro Corporation

One horse that was receiving U. S.

  • Cardiovascular Drug
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Adamis Pharmaceuticals Corporation
  • FM-101 - DRUG PROFILE
  • Adenosine Receptor A3 (ADORA3) - Dormant Products

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Arthritis
  • Cardiovascular Drug
  • Hepatitis
  • Therapy
  • Can-Fite BioPharma Ltd.

Risk factors include personal history of anaphylaxis, allergies or asthma and family history.

  • Cardiovascular Drug
  • Therapy
  • United States
  • World
  • Product Initiative
  • FM-101 - DRUG PROFILE
  • Adenosine Receptor A3 (ADORA3) - Dormant Products

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are ##, ##, ##, ##, ## and ## respectively.

  • Cardiovascular Drug
  • Therapy
  • World
  • Product Initiative
  • Can-Fite BioPharma Ltd.

Risk factors include personal history of anaphylaxis, allergies or asthma and family history.

  • Cardiovascular Drug
  • Therapy
  • United States
  • World
  • Product Initiative

Part ##.

  • Cardiovascular Drug
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Merck & Co., Inc.
  • 5. All the trials included are unique trials.

Patients were randomized ##:## to receive either a six-week course of AEVI-## or placebo, with a one-week follow-up.

  • Cardiovascular Drug
  • Clinical Trial
  • Neurological Disorder
  • Neurology
  • World

The prominent features of this report are - ##.

  • Cardiovascular Drug
  • Clinical Trial
  • Drug Discovery And Development
  • Neurology
  • World
  • IDIOPATHIC (ESSENTIAL) HYPERTENSION - PIPELINE BY SUN PHARMA ADVANCED RESEARCH COMPANY LTD., H1 2016

Its products in preclinical studies include Sun K##, a novel tyrosine kinase inhibitor for the treatment of CML; Sun ##, a topical glucocorticoid for the treatment of allergic rhinitis, asthma and other indications; and L##, a highly selective and potent LTD## antagonist for the treatmen

  • Cardiovascular Drug
  • Hypertension
  • Pharmaceutical
  • United States
  • Company Operations